KDIGO Spoke, Nephrologists Listened: Treatment Paradigms Are Already Shifting (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0847; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "During the same period, budesonide, sparsentan, and atrasentan all saw sharp increases in second-line positioning. Conclusion Publication of the final 2025 KDIGO IgAN guideline accelerated earlier and more aggressive treatment strategies, characterized by foundational SGLT2 inhibitor use and expanded adoption of targeted branded therapies. These findings suggest the updated guideline is influencing real-world IgAN treatment choices and reinforcing aggressive and proteinuria-driven management approaches."
Glomerulonephritis • IgA Nephropathy • Renal Disease
|
|
Ellie McClatchy; Kari McCarthy; Shaunna Newton
|